Showing results (881-890 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 18, 2025
Novel Substituted Pyrazoles as 5‑HT1A Agonists for Treating Neuropsychiatric DiseasesRam W SabnisACS Medicinal Chemistry Letters|June 18, 2025
Novel Desamide Isotryptamine Tetracycles as 5‑HT2C Agonists for Treating Brain DisordersRam W SabnisACS Medicinal Chemistry Letters|February 14, 2024
Neuropharmacological Advances: Harnessing 5-HT2A Receptor Modulators and PsychoplastogensRobert B KargboACS Medicinal Chemistry Letters|February 14, 2024
Development of Novel Membrane Disrupting Lipoguanidine Compounds Sensitizing Gram-Negative Bacteria to AntibioticsSeong-Heun Kim, Charlotte K Hind, Guilherme F S Fernandes, et al.ACS Medicinal Chemistry Letters|February 14, 2024
Selective (α)-l-Rhamnosylation and Neuroprotective Activity Exploration of Cardiotonic SteroidsRyan Rutkoski, Lucas Kniess Debarba, Lukas Stilgenbauer, et al.ACS Medicinal Chemistry Letters|February 14, 2024
Emopamil-Binding Protein Inhibitors for Treating Multiple SclerosisRam W SabnisACS Medicinal Chemistry Letters|March 20, 2024
Pyrrolidinone Derivatives as NIK Inhibitors for Treating Inflammatory and Autoimmune DiseasesRam W SabnisACS Medicinal Chemistry Letters|March 20, 2024
Novel-Type GABAB PAMs: Structure-Activity Relationship in Light of the Protein StructureBalázs Krámos, Zsuzsa Hadady, Attila Makó, et al.ACS Medicinal Chemistry Letters|March 20, 2024
Novel Heterocyclic Compounds for Treating Huntington's DiseaseRam W Sabnis, Anika R SabnisACS Medicinal Chemistry Letters|March 20, 2024
Novel Tetrahydropyrido[3,4-d]pyrimidines as HPK1 Inhibitors for Treating Cancer, Inflammatory, and Autoimmune DiseasesRam W SabnisPageof 438